Crescita Therapeutics (TSE:CTX) Sets New 12-Month High – What’s Next?

Shares of Crescita Therapeutics Inc. (TSE:CTX) hit a new 52-week high on Tuesday . The stock traded as high as C$0.75 and last traded at C$0.74, with a volume of 17030 shares trading hands. The stock had previously closed at C$0.75.

Crescita Therapeutics Stock Performance

The company has a quick ratio of 2.29, a current ratio of 3.12 and a debt-to-equity ratio of 2.98. The stock has a fifty day moving average price of C$0.55 and a 200-day moving average price of C$0.49. The firm has a market cap of C$13.77 million, a price-to-earnings ratio of 37.00 and a beta of -0.39.

Crescita Therapeutics (TSE:CTX) last issued its quarterly earnings results on Tuesday, March 31st. The company reported C($0.04) earnings per share for the quarter. Crescita Therapeutics had a return on equity of 2.92% and a net margin of 2.07%.The company had revenue of C$5.96 million for the quarter.

About Crescita Therapeutics

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.